Latest News & Updates

Breaking News

  • 2 hours ago

  • Vaibhavi M.

Ocugen Appoints Rita Johnson-Greene, A Veteran Leader With 20+ Years Of Experience As Chief Financial Officer,
Breaking News
Oragenics Advances ONP-002 Toward Phase 2 Trials For Mild Traumatic Brain Injury mTBI

Vaibhavi M.

Chugai Presents NXT007 Switch Data From Emicizumab Phase I/II Study Supports Safe Transition To NXT007 In Haemophilia A

Vaibhavi M.

USFDA Completes Inspection of Anuh Pharma’s Facilities Without Form 483 Observation

Team Pharma Now

Roche’s Fenebrutinib Matches OCREVUS In Phase III PPMS Study, Shows Disability-Risk Reduction, Data Highlight Fenebrutinib’s Potential In Progressive Multiple Sclerosis

Vaibhavi M.

Other trending news you may like to read

Ocugen Appoints Rita Johnson-Greene, A Veteran Leader With 20+ Years Of Experience As Chief Financial Officer,

Ocugen appoints gene therapy veteran Rita Johnson-Greene as CFO to support upcoming BLAs and growth strategy.

Vaibhavi M.

Pharma Now

Oragenics Advances ONP-002 Toward Phase 2 Trials For Mild Traumatic Brain Injury mTBI

Oragenics advances intranasal ONP-002 toward Phase 2 trials as a potential first drug treatment for concussion and mTBI.

Vaibhavi M.

Pharma Now

Chugai Presents NXT007 Switch Data From Emicizumab Phase I/II Study Supports Safe Transition To NXT007 In Haemophilia A

Chugai reports Phase I/II data showing safe switch from emicizumab to NXT007 in hemophilia A without washout.

Vaibhavi M.

Pharma Now

USFDA Completes Inspection of Anuh Pharma’s Facilities Without Form 483 Observation

Anuh Pharma’s Tarapur manufacturing site clears USFDA inspection with no observations, underscoring global GMP compliance.

Team Pharma Now

Pharma Now